Related Experiment Video
Updated: Apr 24, 2026

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
Published on: December 7, 2012
Emerging microbial threats to the United States blood supply
1America's Blood Centers, Washington, DC, USA.
Purpose Of Review:
In this short review, several emerging agents are described to demonstrate potential responses of the blood community to emerging and potentially emerging infections.
Recent Findings:
Critical questions are raised as we consider appropriate approaches to these agents. Can we identify risk thresholds below which interventions are not required, that is, are there tolerable infectious risks of transfusion? Who are the stakeholders responsible for that determination? What is the role of health economic analysis for informing those decisions? If we decide that cost-utility thresholds for transfusion medicine are appropriately several fold higher than for the rest of clinical medicine, who has responsibility for being certain whether those priorities are funded?
Summary:
Four agents will be discussed to highlight the evolving considerations in response to these considerations.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Microorganisms in Medicine and Therapeutics
Investigation of Disease Outbreaks
Bacterial Signaling
Automated Microbial Diagnostics

